NCT05372653View on ClinicalTrials.gov

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

December 29, 2022

Study Completion Date

November 29, 2023

Conditions
Atopic Dermatitis (AD)
Interventions
DRUG

OPA-15406

0.3% or 1% ointment, topical, twice daily, for 52 weeks

Trial Locations (1)

Unknown

Sotobo Children's Clinic, Isumi

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY